Footnotes: 1: Dan Witters, Mary Page James, Obesity Rate Declining in U.S., Gallup, October 2025 2: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using Google Trends, Reuters, Business Insider, CNBC, ro, Weightwatchers, hims&hers, 23andMe, Noom, Digiday, Edo, Fierce Healthcare, Morgan Stanley, KFF, NIH, ICER 3: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using Circana and Earnest Analytics 4: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using Circana Complete Consumer Total US, June 2022-June 2024 5: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using Circana, Euromonitor, Morgan Stanley Research 6: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using Morgan Stantely 7: Supra n.4 8: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using Stephens, Circana, Morgan Stanley Research 9: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using AlphaWise, Census Bureau, Carbon Arc Medical & Pharmacy Open Claims, Morgan Stanley Research 10: FTI Consulting analysis of publicly-available and licensed subscription data (2026) using GlobalData, Numerator Data, Company Reports, Piper Sandler & Co Published July 02, 2026 Key Contacts Managing Director

10.2147/ITT.S499605 Immunotargets Ther
Current batch No active lot No active lot is published for this material yet
Our program restores it with clinical structure: a personalized protocol, tracked outcomes, and clinician oversight
Community-reported research-peptide dosing typically uses 0.5-1 mg subcutaneous daily during loading (1-2 weeks), then 0.5-1 mg 2-3x weekly for maintenance